Dianthus Therapeutics's total assets for Q2 2025 were $326.08M, a decrease of -6.46% from the previous quarter. DNTH total liabilities were $23.00M for the fiscal quarter, a 15.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.